🔬 This Week’s Top Biotech News Here are the biggest stories shaping the world of biotechnology this week 👇 Eisai – Health Canada Grants Authorization for LEQEMBI® (lecanemab) for Early Alzheimer’s DiseaseBiopharma Embraces Synthetic BiologySanofi-Aventis Canada – Dupixent® (dupilumab injection) approved for COPDStockWatch: Intellia Shares Sink as Clinical Hold Follows Safety SetbackBird Flu’s Human Risk Spurs Phage Therapy ResearchThis Retina Implant Lets People with Vision Loss Do a Crosswor...
All content for BioTech Weekly is the property of Ernst Oberortner and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
🔬 This Week’s Top Biotech News Here are the biggest stories shaping the world of biotechnology this week 👇 Eisai – Health Canada Grants Authorization for LEQEMBI® (lecanemab) for Early Alzheimer’s DiseaseBiopharma Embraces Synthetic BiologySanofi-Aventis Canada – Dupixent® (dupilumab injection) approved for COPDStockWatch: Intellia Shares Sink as Clinical Hold Follows Safety SetbackBird Flu’s Human Risk Spurs Phage Therapy ResearchThis Retina Implant Lets People with Vision Loss Do a Crosswor...
🔬 Corporate Updates & Partnerships Zymeworks to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025OBIO® Paves the Way for Companies to Succeed in Canada as a Stepping Stone to New Global Markets💊 Clinical Trials & Therapeutic Breakthroughs 4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee OsteoarthritisAptose Receives Second Advance under the Loan Agreement with Hanmi Pharmaceutical ...
BioTech Weekly
🔬 This Week’s Top Biotech News Here are the biggest stories shaping the world of biotechnology this week 👇 Eisai – Health Canada Grants Authorization for LEQEMBI® (lecanemab) for Early Alzheimer’s DiseaseBiopharma Embraces Synthetic BiologySanofi-Aventis Canada – Dupixent® (dupilumab injection) approved for COPDStockWatch: Intellia Shares Sink as Clinical Hold Follows Safety SetbackBird Flu’s Human Risk Spurs Phage Therapy ResearchThis Retina Implant Lets People with Vision Loss Do a Crosswor...
